Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Bio-Rad Labs Inc. A buy Wells Fargo & Company

Bio-Rad Labs Inc. A
Start price
€355.00
16.06.23 / 50%
Target price
€502.10
16.06.24
Performance (%)
-25.32%
End price
€265.10
17.06.24
Summary
This prediction ended on 17.06.24 with a price of €265.10. The price of Bio-Rad Labs Inc. A has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.32%. Wells_Fargo___Compan has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Bio-Rad Labs Inc. A -1.296% -1.296% -17.928%
iShares Core DAX® 2.821% -1.953% 15.071%
iShares Nasdaq 100 5.285% -5.092% 29.254%
iShares Nikkei 225® 3.687% -4.221% 14.286%
iShares S&P 500 3.577% -2.240% 25.546%

Comments by Wells_Fargo___Compan for this prediction

In the thread Bio-Rad Labs Inc. A diskutieren
Prediction Buy
Perf. (%) -25.32%
Target price 502.095
Change
Ends at 16.06.24

Bio-Rad Laboratories, Inc. (NYSE: BIO) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $550.00 price target on the stock.
Ratings data for BIO provided by MarketBeat

Wells Fargo & Company 
0
Report Share
16.06.23
In the thread Trading Bio-Rad Labs Inc. A
Prediction Buy
Perf. (%) -25.32%
Target price 502.095
Change
Ends at 16.06.24

Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten

Wells Fargo & Company 
0
Report Share
17.06.24

Stopped prediction by Wells_Fargo___Compan for Bio-Rad Labs Inc. A

buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€364.80
07.08.23
€477.33
07.08.24
-20.83%
08.08.24

Wells Fargo & Company 
07.08.23 50%